Cowen Inc’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Cowen Inc’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,650	Closed	-$186K	–	534
2018 Q3	$186K	Buy	+4,650	New	+$132K	0.02%	259

Other funds holding MRNS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Cowen Inc's MRNS Position: Q4 2018 in Review

Cowen Inc sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2018, closing a stake of 4,650 shares — an estimated $186K sold.

Cowen Inc first reported a position in MRNS in Q3 2018 and held it in 1 quarter. The position peaked at $186K in Q3 2018. 90 funds tracked by Wall St. Rank hold MRNS as of Q4 2018.

Cowen Inc reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2018 after selling out during the quarter.
Cowen Inc sold 4,650 Marinus Pharmaceuticals, Inc shares in Q4 2018, an estimated $186K.
Cowen Inc first reported a position in Marinus Pharmaceuticals, Inc in Q3 2018 and held it in 1 quarter.
Cowen Inc's Marinus Pharmaceuticals, Inc position peaked at $186K in Q3 2018.
90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.